FDA Lifts Clinical Hold On PharmAthene's SparVax Anthrax Vaccine
The U.S. Food and Drug Administration (FDA) has lifted the clinical hold previously placed on a proposed Phase II study of SparVax, a next generation recombinant anthrax vaccine, PharmAthene, Inc.…